Lightnews — Scholar-powered news

Clinical Infectious Diseases @cidjournal.bsky.social · 17h

Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product Recommendations

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4h5Pi7d

2 4

Clinical Infectious Diseases @cidjournal.bsky.social · 22h

Role of local and population-based data in Advanced HIV Disease in the ICU

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KJ3GWW

1 2

Clinical Infectious Diseases @cidjournal.bsky.social · 1d

Advanced HIV Disease in the ICU: Experience from a Spanish Cohort

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IRGUM4

2 3

Clinical Infectious Diseases @cidjournal.bsky.social · 1d

Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of care.

✅ Just Accepted
#IDSky

Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of care

People with advanced HIV disease (CD4 ≤200 cells/µL) remain at high risk for opportunistic infections, hospitalization, and death, despite access to antiretroviral therapy (ART). We evaluated serum C-reactive protein (CRP) as a predictor of 30-day hospitalization or death among...

bit.ly

1 1

Clinical Infectious Diseases @cidjournal.bsky.social · 2d

Precision Prevention of Tuberculosis in Biologic Therapy: Lessons Beyond Screening Strategies

✅ Just Accepted
#IDSky
🔗 https://bit.ly/42vkeYy

1 3

Clinical Infectious Diseases @cidjournal.bsky.social · 2d

AI in ID practice: diagnostics, stewardship, education & surveillance. CID wants papers exploring real-world benefits & risks. Proposals due Nov 2.

Learn more ⬇️

Joint Call for Papers: Leveraging AI Technologies for Discoveries and Solutions in Infectious Diseases

The IDSA journals are seeking papers focused on artificial intelligence (AI) and how it enhances and impacts infectious diseases. The journals are interested in

bit.ly

3 2

Clinical Infectious Diseases @cidjournal.bsky.social · 3d

Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4pWzRCA

Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity

Repeated nirmatrelvir/ritonavir treatment in participants with COVID-19 rebound was safe and well tolerated. In this group of participants, there was no cl

bit.ly

1 4

Clinical Infectious Diseases @cidjournal.bsky.social · 3d

The Role of ß-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4mH8Hwr

1 3 3

Clinical Infectious Diseases @cidjournal.bsky.social · 4d

Secondary Pneumococcal Disease in Veterans with Viral Respiratory Infections: a Follow Up

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WhVjUG

1 3 3

Clinical Infectious Diseases @cidjournal.bsky.social · 4d

COVID-19 and Bacterial Pneumonia: Protective Effect or Diagnostic Bias?

✅ Just Accepted
#IDSky

🔗 https://bit.ly/4mPrcPw

1 3 6

Clinical Infectious Diseases @cidjournal.bsky.social · 5d

Risk factors associated with progression to clinical Candida auris infection among adults with previous colonization: Florida, 2019-2023

✅ Just Accepted
#IDSky

Risk factors associated with progression to clinical Candida auris infection among adults with previous colonization—Florida, 2019–2023

We investigated factors associated with clinical progression of Candida auris cases following documented colonization among Florida patients. These finding

bit.ly

2 5

Clinical Infectious Diseases @cidjournal.bsky.social · 5d

Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4o1oLdK

1 2 5

Clinical Infectious Diseases @cidjournal.bsky.social · 6d

Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection

✅ Just Accepted
#IDSky

🔗 https://bit.ly/3IrezvX

1 3 5

Clinical Infectious Diseases @cidjournal.bsky.social · 6d

(Un)masking TB

✅ Just Accepted
#IDSky

🔗 https://bit.ly/46vfsN5

1 1

Clinical Infectious Diseases @cidjournal.bsky.social · 7d

Severity of Clinical Presentation and Outcomes in Hospitalized Adult Patients with Influenza by Type and Subtype, United States?2017?2020

✅ Just Accepted
#IDSky
🔗 https://bit.ly/48FSdkL

2

Clinical Infectious Diseases @cidjournal.bsky.social · 7d

Carbapenemase-producing Enterobacterales in pets: a new threat from veterinary clinics

✅ Just Accepted
🔗 https://bit.ly/4gK0jLe

1 2

Clinical Infectious Diseases @cidjournal.bsky.social · 8d

REPRIEVE Analysis of New Cardiovascular Risk Calculators in HIV: Underpredicting Risk Means Preventing Fewer Heart Attacks

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gXz8wQ

2 2

Clinical Infectious Diseases @cidjournal.bsky.social · 8d

Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2

✅ Just Accepted
#IDSky
🔗 https://bit.ly/48GsybG

2 2

Clinical Infectious Diseases @cidjournal.bsky.social · 9d

Human Cases of Carbapenemase-Producing Escherichia coli Linked to Spread Between Animals and the Environment in a Veterinary Facility- Massachusetts, USA, 2023

✅ Just Accepted
🔗 https://bit.ly/46wmy46

Human Cases of Carbapenemase-Producing Escherichia coli Linked to Spread Between Animals and the Environment in a Veterinary Facility- Massachusetts, USA, 2023

Carbapenemase-producing Enterobacterales (CPE), traditionally thought to cause hospital-acquired infection in humans, are now emerging as agents of both community-acquired infections in humans as well as hospital-acquired infections in pets.

bit.ly

1 3

Clinical Infectious Diseases @cidjournal.bsky.social · 9d

Actually, it may be time to return to colistin and meropenem in some patients infected with Carbapenem-resistant A. baumannii (CRAB)

✅ Just Accepted
#IDSky
🔗 https://bit.ly/48rvo4z

2 3

Clinical Infectious Diseases @cidjournal.bsky.social · 10d

It is time to go beyond the association between colistin and meropenem for invasive carbapenem-resistant Acinetobacter baumannii infections

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ksetom

1 2 5

Clinical Infectious Diseases @cidjournal.bsky.social · 10d

Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gPh0oz

Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial

AbstractBackground. The duration of infectiousness following pulmonary tuberculosis treatment initiation remains uncertain. We aimed to assess whether a bu

bit.ly

1 2

Clinical Infectious Diseases @cidjournal.bsky.social · 11d

Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3W8Fb7U

1 2

Clinical Infectious Diseases @cidjournal.bsky.social · 12d

Beyond the Sequence: Operationalizing Whole Genome Sequencing for Real-Time Infection Control in LMIC Healthcare Settings

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gRG9iI

1 6

Clinical Infectious Diseases @cidjournal.bsky.social · 12d

Xpert MTB/RIF® cycle threshold as a marker of TB disease severity; Implications for TB treatment stratification

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WbLI1G

1 6 11